Abstract
Previous studies from our laboratory have demonstrated that pyruvate, an endogenous α-keto acid metabolite, has a protective effect against oxidative stress induced damage to the ocular tissues including the lens, in which in addition to exerting its protective effect against tissue damage caused by oxyradicals generated under organ culture, it is also found effective in preventing actual cataract formation in vivo in animal models undergoing direct oxidative stress as well as in diabetes. In the latter studies, pyruvate was administered mixed with diet and drinking water. However, with the view of the desirability of treating eye diseases by topical administration of the pharmacological agents, the present studies were conducted to determine the penetrability of pyruvate through the cornea to the aqueous humor and the lens following its topical administration as its ester, ethyl pyruvate (EP). These experiments were done in CD-1 mice. After instillation of the drops in the conjunctival cul-de-sac, aqueous humor samples were aspirated at the desired times and analyzed for pyruvate. In a separate group of animals, analyses were done also in the lens. Analyses were done spectrophotometrically by monitoring the decrease in absorption of NADH due to the reduction of pyruvate to lactate by lactate dehydrogenase. The levels of pyruvate were found to be significantly elevated in both the aqueous humor as well as the lens, the peak concentrations being 4.7 and 3.6 mM, respectively. Such levels have been previously shown to be effective in exerting its antioxidant effects. The results are therefore considered pharmacological significant from the point of view of its potential use for topical treatment of cataracts induced by oxidative stress and diabetes.
References
Jacques PF (1999) The potential preventive effects of vitamins for cataract and age-related macular degeneration. Int J Vitam Nutr Res 69(3):198–205
Varma SD, Srivastava VK, Richards RD (1982) Photoperoxidation in lens and cataract formation: preventive role of superoxide dismutase, catalase and vitamin C. Ophthalmic Res 14(3):167–175
Spector A, Garner WH (1981) Hydrogen peroxide and human cataract. Exp Eye Res 33(6):673–681
Varma SD, Morris SM (1988) Peroxide damage to the eye lens in vitro prevention by pyruvate. Free Radic Res Commun 4(5):283–290
Varma SD, Hegde KR, Kovtun S (2006) Oxidative damage to lens in culture: reversibility by pyruvate and ethyl pyruvate. Ophthalmologica 220(1):52–57
Varma SD, Ramachandran S, Devamanoharan PS, Morris SM, Ali AH (1995) Prevention of oxidative damage to rat lens by pyruvate in vitro: possible attenuation in vivo. Curr Eye Res 14(8):643–649
Varma SD, Hegde KR, Kovtun S (2005) Attenuation and delay of diabetic cataracts by antioxidants: effectiveness of pyruvate after onset of cataract. Ophthalmologica 219(5):309–315
Maurice DM (1955) Influence on corneal permeability of bathing with solutions of differing reaction and tonicity. Br J Ophthamol 39:463–473
Chidlow G, Wood JPM, Graham M, Osborne NN (2005) Expression of monocarboxylate transporters in rat ocular tissues. Am J Physiol Cell Physiol 288:C416–C428
Acknowledgments
The authors are thankful for the financial support of NEI, NIH, and Research to Prevent Blindness, Inc.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hegde, K.R., Kovtun, S. & Varma, S.D. Intraocular penetration of pyruvate following its topical administration in mice. Mol Cell Biochem 338, 87–90 (2010). https://doi.org/10.1007/s11010-009-0341-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-009-0341-9